‘Case of self-contradiction’: FDA advise vs Sinovac despite EUA questioned | Inquirer News
Close  

‘Case of self-contradiction’: FDA advise vs Sinovac despite EUA questioned

/ 03:08 PM February 23, 2021
‘Case of self-contradiction’: FDA advise vs Sinovac despite EUA questioned

MADE IN CHINA A doctor shows the Sinovac vaccine.  AFP File Photo

MANILA, Philippines — Calling it a case of “self-contradiction,” some lawmakers are seeking clarification over Food and Drug Administration’s (FDA) recommendation not to administer  Sinovac’s Covid-19 vaccine to healthcare workers and senior citizens even if it also granted the jab an emergency use authorization (EUA).

House Minority Leader Joseph Stephen Paduano said FDA’s “contradicting statements” only cast doubts on the efficacy of the China-made vaccine as it also signifies that the EUA issued to Sinovac was “half-baked.”

ADVERTISEMENT

Paduano likewise noted that “rather than shed light on the use of the vaccine, the FDA has further eroded public trust and confidence in inoculation.”

And so, for Paduano, FDA should issue a classificatory statement regarding the matter at the soonest time possible.

FEATURED STORIES

Bayan Muna Rep. Carlos Isagani Zarate also raised concerns over the FDA’s advice against the use of Sinovac on healthcare workers and senior citizens, as he hit the national government’s “dilly-dallying” amid the pandemic.

“Bakit kasi parang sa Sinovac/CoronaVac lang parang nakaasa ang vaccination program ng administrasyon? (Why is the administration depending on Sinovac/CoronaVac for the vaccination program?),” Zarate asked.

Sinovac’s vaccine is named CoronaVac.

According to Zarate,  the arrival and use of other Covid-19 vaccines should be expedited so that frontline workers in the healthcare sector and the elderly can be inoculated soon.

“The longer this takes, the longer will it take also for our economy to prosper. This dilly-dallying affects not only our economy but also the very lives of our people this has to stop,” Zarate said.

To recall, FDA on Monday announced that it has granted a EUA to Sinovac, a day before the donated shipment of 600,000 vaccine doses from China was supposed to arrive.

However, FDA Director-General Eric Domingo said the vaccine’s efficacy rate on healthcare workers stands at 50.4%, which makes it not the best vaccine to be given to medical frontliners who are exposed to Covid-19 patients.

KGA

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Coronavirus, COVID-19, COVID-19 Vaccine, Health, pandemic, SARS-CoV-2, Sinovac, vaccine, Virus
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.